Thalidomide: An old drug with new clinical applications

被引：11

作者：

Baidas, S

Tfayli, A

Bhargava, P

机构：

[1] Georgetown Univ Hosp, Lombardi Canc Ctr, Washington, DC 20007 USA

[2] Univ Massachusetts, Med Ctr, Div Hematol Oncol, Worcester, MA 01655 USA

来源：

CANCER INVESTIGATION | 2002年 / 20卷 / 5-6期

关键词：

D O I：

10.1081/CNV-120002498

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：835 / 848

页数：14

共 119 条

[1]

BAHMER FA, 1982, ACTA DERM-VENEREOL, V62, P449

[2] Phase II evaluation of thalidomide in patients with metastatic breast cancer [J].

Baidas, SM ;

Winer, EP ;

Fleming, GF ;

Harris, L ;

Pluda, JM ;

Crawford, JG ;

Yamauchi, H ;

Isaacs, C ;

Hanfelt, J ;

Tefft, M ;

Flockhart, D ;

Johnson, MD ;

Hawkins, MJ ;

Lippman, ME ;

Hayes, DF .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (14) :2710-2717

[3]

BARLOGIE B, 2000, P AM SOC CLIN ONC NE, V19

[4] Inhibition of angiogenesis by thalidomide requires metabolic activation, which is species-dependent [J].

Bauer, KS ;

Dixon, SC ;

Figg, WD .

BIOCHEMICAL PHARMACOLOGY, 1998, 55 (11) :1827-1834

[5] EFFECT OF THALIDOMIDE ON OROGENITAL ULCERATION [J].

BOWERS, PW ;

POWELL, RJ .

BRITISH MEDICAL JOURNAL, 1983, 287 (6395) :799-800

[6]

CANEPA L, 2000, P AM SOC HEM SAN FRA

[7] TREATMENT OF CUTANEOUS AND PULMONARY SARCOIDOSIS WITH THALIDOMIDE [J].

CARLESIMO, M ;

GIUSTINI, S ;

ROSSI, A ;

BONACCORSI, P ;

CALVIERI, S .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1995, 32 (05) :866-869

[8]

CHAPON F, 1985, REV NEUROL-FRANCE, V141, P719

[9]

CHEN TL, 1989, DRUG METAB DISPOS, V17, P402

[10]

Cherouati K, 1996, ANN DERMATOL VENER, V123, P375

← 1 2 3 4 5 6 7 8 9 10 →